Topiramate Induces Weight Loss and Improves Insulin Sensitivity in Dietary Obese Rats: Comparison to Sibutramine

Total Page:16

File Type:pdf, Size:1020Kb

Topiramate Induces Weight Loss and Improves Insulin Sensitivity in Dietary Obese Rats: Comparison to Sibutramine European Review for Medical and Pharmacological Sciences 2011; 15: 1187-1195 Topiramate induces weight loss and improves insulin sensitivity in dietary obese rats: comparison to sibutramine D.M. ABO-ELMATTY, S.A. ZAITONE* Department of Biochemistry and *Department of Pharmacology and Toxicology; Faculty of Pharmacy, Suez Canal University, Ismailia (Egypt) Abstract. – Background and Objectives: BP = Blood pressure Topiramate is newly approved as anticonvulsant DBP = Diastolic blood pressure that seems to promote body weight loss in hu- FAs = Fatty acids mans. The present study was designed to evalu- FDA = Food and Drugs Administration ate the weight-controlling properties of topiramate in dietary obese female rats in comparison with HDL-C = High density lipoprotein cholesterol sibutramine. HFD = High fat diet Materials and Methods: Fifty rats were as- HOMA-IR index = Homeostasis model assess- signed as normal, high fat diet (HFD), HFD + sibu- ment insulin resistance in- tramine (7.5 mg/kg, p.o.), HFD + topiramate (25 dex mg/kg, p.o.) and HFD + topiramate (50 mg/kg, LDL-C = Low density lipoprotein cholesterol p.o.). Body weight was registered, anxiety was NPD = Normal palatable diet tested in Vogel’s test and blood pressure (BP) was measured. In addition, liver index, adipose tissue R-QUICKI = Revised quantitative insulin sen- index, fasting blood glucose and serum lipid pro- sitivity check index file were measured in all groups. Further, serum SBP = Systolic blood pressure insulin, leptin and adiponectin were determined. TAG = Triacylglycerol Results: Feeding with HFD induced a significant TC = Total cholesterol increase in body weight of rats as well as insulin resistance and serum lipids as compared to nor- mal group (p<0.05). These measurements were suppressed by sibutramine treatment. However, a significant elevation in BP and anxiety behavior Introduction were detected as compared with HFD group (p<0.05). Topiramate (50 mg/kg, p.o.) group The current obesity pandemic imposes a major showed weight loss, improved insulin resistance, global disease burden. The rise in obesity will be lessened anxiety behavior without influence on BP. accompanied by increases in related disorders Discussion: Our data ensures the findings that topiramate has a weight controlling properties such as diabetes, hypertension and heart 1 with no anxiogenic or hypertensive effects. Fur- diseases . Obesity has been traditionally chal- ther investigations are needed to determine the lenged with diets, exercise and behavioral modi- utility of topiramate in the clinical management of fication. These techniques have still so far failed obesity. to halt the obesity pandemic. Given the enormity of the obesity problem, adjunctive pharmacother- Key Words: apy provides an attractive solution2. However, Obesity, Topiramate, Weight control, Anxiety, Blood very few drugs have been developed for obesity Pressure. treatment and those that are approved have only limited success1. When sibutramine was received approval from Abbreviations the American Food and Drugs Administration (FDA) in November of 1997, it represented the AMPA = α-amino-3-hydroxy-5-methyl-4- first unique agent of a new class of medications isoxazolepropionic acid for the treatment of obesity. Sibutramine is a Corresponding Author: Sawsan A. Zaitone, Ph.D; e-mail: sawsanzaitune@hotmail.com 1187 D.M. Abo-Elmatty, S.A. Zaitone pharmacological agent with selective norepi- NPD for five months; the remaining rats received nephrine, serotonin and a lesser extent, HFD for three months to establish diet-induced dopamine, reuptake inhibitor3. Cardiovascular obesity. Table I illustrates the formula of the diet: side effects include an increase in systolic and di- it provides 17% energy as carbohydrates, 25% as astolic BP, and an increase in heart rate, tachy- protein, and 58% as fat as a percentage of total cardia and palpitations. These adrenergic side ef- kcal/g10. Rats receiving HFD were divided equal- fects are a particular concern for patients with ly into four groups. One group returned to nor- hypertension. Additionally, an increase appear- mal diet and the other groups returned to normal ance of mood-related disorders has been reported diet and treated with sibutramine (7.5 mg/kg/day, during sibutramine treatment such as insomnia4 p.o.)11 or topiramate (25 mg/kg/day, p.o.) or topi- and generalized anxiety and panic disorders5. ramate (50 mg/kg/day, p.o.)12 for additional two However, in October of 2010, sibutramine was months. The changes in body weight were moni- removed from the US market due to an evident tored every week. The animals were cared for in increased risk of heart attack and stroke. After accordance with the principles and guidelines of withdrawal of sibutramine, only one medication- the Canadian Council on care and use of experi- orlistat-has been approved by the FDA for long- mental animals. All experimental procedures fol- term use in the treatment of obesity6. Reported lowed were in accordance with guidelines of the side effects of orlistat include flatus with dis- Institutional Animal Care and Use Committee. charge and oily stool. Severe problems such as fecal urgency, incontinence and abdominal pain Drugs can also occur2. The adverse effects of these Sibutramine hydrochloride (Medical Union agents highlighted a continued need for safe and Pharmaceuticals, Ismailia, Egypt) was dissolved effective medications for the treatment of obesity in distilled water and administered orally. Topira- with a positive impact on health related quality mate (Delta Pharm, 10th of Ramadan City, Egypt) of life. was dissolved in 2% tween-80 solution. Topiramate is a structurally novel therapeutic agent currently approved for marketing as an Testing Anxiety in Vogel’s Proconflict antiepileptic drug. Topiramate has been reported Situation Test to exert multiple pharmacological effects that Briefly, after 24 hrs of water deprivation, each may determine its broad range of activities in- rat was placed in the cage of the anxiometer. The cluding anticonvulsant, analgesic, and mood-sta- cage is a Plexiglas box (25×25×25 cm) equipped bilizing properties7. Topiramate has been report- with a grid floor of stainless steel bars and a ed to cause a decrease in body weight in some drinking bottle containing water (Anxiometer epileptic patients during clinical evaluation8. Model, LE 3206, Panlab s.l., Barcelona, Spain) These observations prompted studies to elucidate was used for training and testing for animals the mechanistic basis of topiramate induced where it was given an opportunity to consume weight loss in animals9. Therefore, the present study was designed for evaluation of the weight controlling properties of Table I. Composition of the high fat diet. topiramate in dietary obese rats in comparison with sibutramine. Further, we aimed to explore Amount the role of improving insulin resistance or regula- Ingredients (g/kg)e tion of adipokines in this pharmacological effect. Powdered NPD1 365 Lard2 310 Casein3 250 4 Materials and Methods Cholesterol 10 Vitamin and mineral mix5 60 DL-Methionine6 03 Animals and Experimental Design Yeast powder7 01 Fifty female albino rats were housed in stan- 8 dard cages and maintained under controlled room Sodium chloride 01 temperature (25 ± 3) and normal light-dark cycle 1,2,7,8Purchased from the market; 3Difco (Becton Dickinson, with free access to food and water. Rats had ini- France), 4Oxford Lab, Mumbai, India; 5,6Sigma-Aldrich, tial body weight 150-180 g. Ten rats received MO, USA; 8ADWIC Co., Cairo, Egypt. 1188 Topiramate induces weight loss and improves insulin sensitivity in dietary obese rats water from a drinking bottle. A sharp decrease high HOMA index denotes low insulin sensitivi- of the number of drinking episodes testifies to ty23. To assess insulin sensitivity, another derived the existence of anxiety and increased fear in an- index was suggested, i.e., the revised quantitative imal13,14. insulin sensitivity check index (R-QUICKI) = [1/log fasting insulin (μU/ml) + log fasting glu- Measuring Systemic Arterial cose (mg/dl)]24. Blood Pressure Rats were deeply anaesthetized with thiopental Statistical Analysis sodium (40 mg/kg, i.p.)15 and placed on a temper- The results are expressed as mean ± SEM. The ature-controlled panel. A laparotomy was per- data was analyzed using Statistical Package of formed and a non-occlusive, polyvinyl catheter Social Sciences (SPSS) program version 16, was implanted in the abdominal aorta, caudal to Chicago, IL, USA. One-way analysis of vari- the kidneys, through a puncture wound in the ance, ANOVA, followed by Bonferroni’s multi- aortic wall made with the tip of an L-shaped 18- ple comparisons test were employed for statisti- gauge needle. The catheter was fixed by tying a cal analysis. A value of p≤0.05 was considered to ligature. The arterial catheter was filled with he- be statistically significant. parin solution (1.000 USP U/ml)16 and connected to digital BP monitor (Columbus Instruments, OHIO, 43204, USA) for BP recording. Mean systolic BP (SBP) and diastolic BP (DBP) were Results measured for each group. Body Weight Gain, Liver Index and Blood Sampling and Adipose Tissue Index Biochemical Analysis In the current study, HFD group showed a sig- After measuring the BP, blood samples were nificant increase in the percentage body weight collected by cardiac puncture. Serum was sepa- gain as compared to NPD group (53 ± 6 vs. 17 ± rated and kept at –80°C until performing the bio- 2 g, respectively, p≤0.05, Table II). Treatment chemical measurements. Serum insulin was de- with sibutramine (7.5 mg/kg/day, p.o.) for two termined using ultra sensitive rat insulin ELISA months significantly reduced percentage body kit (Crystal Chem Inc., Downers Grove, IL weight gain to 31 ± 3 g (p≤0.05). Similarly, treat- 60515, USA)17. Serum leptin was measured by ment with the high dose of topiramate (50 rat leptin ELISA kit (Crystal Chem Inc., USA)18. mg/kg/day, p.o.) reduced the percentage weight Serum adiponectin was detected by rat gain value significantly to 36 ± 5 g as compared adiponectin ELISA kit (AdipoGen Inc.
Recommended publications
  • Kava (Piper Methysticum) and Its Methysticin Constituents Protect Brain Tissue Against Ischemic Damage in Rodents
    5 Refs: Arletti R et al, Stimulating property of Turnera diffusa and Pfaffia paniculata extracts on the sexual-behavior of male rats. Psychopharmacology 143(1), 15-19, 1999. Berger F, Handbuch der drogenkunde . Vol 2, Maudrich, Wien, 1950. Martinez M, Les plantas medicinales de Mexico . Cuarta Edicion Botas Mexico , p119, 1959. Tyler VE et al, Pharmacognosy , 9 th edition, Lea & Febiger, Philadelphia, 1988. KAVA ( Piper methysticum ) - A REVIEW The Kava plant (Piper methysticum) is a robust, well-branching and erect perennial shrub belonging to the pepper family (Piperaceae). The botanical origin remains unknown, although it is likely that early Polynesian explorers brought the plant with them from island to island. Numerous varieties of Kava exist, and today it is widely cultivated in several Pacific Island countries both for local use as well as the rapidly growing demand for pharmaceutical preparations. The dried rhizomes (roots) are normally used. The first description to the western world of the ceremonial use of an intoxicating beverage prepared from Kava was made by Captain James Cook following his Pacific voyage in 1768. The drink, prepared as an infusion in an elaborate manner after first chewing the root, is consumed on formal occasions or meetings of village elders and chiefs, as well as in reconciling with enemies and on a more social basis. It remains an important social custom in many Pacific Island countries today. Most of the islands of the Pacific possessed Kava prior to European contact, particularly those encompassed by Polynesia, Melanesia and Micronesia. After drinking the Kava beverage a pleasantly relaxed and sociable state develops, after which a deep and restful sleep occurs.
    [Show full text]
  • Alternative Treatments for Depression and Anxiety
    2019 PCB Conference: Strickland Benzodiazepines (BZDs), Herbal and Alternative Treatments for Anxiety & Depression BZD Learning Objectives • List at least three uses for benzodiazepines • Discuss at least two risk factors associated with benzodiazepine prescriptions Craig Strickland, PhD, Owner Biobehavioral Education and Consultation https://sites.google.com/site/bioedcon 1 2 BZD Pharmacokinetics Clinical Uses of BZDs Generic Name Trade Name Rapidity ½ Life Dose (mg) • Treat a variety of anxiety disorders alprazolam Xanax Intermediate Short 0.75-4 • Hypnotics • Muscle relaxants chlordiaze- Librium Intermediate Long 15-100 poxide • To produce anterograde amnesia clonazepam Klonopin Intermediate Long 0.5-4 • Alcohol & other CNS depressant withdrawal • Anti-convulsant therapy diazepam Valium Rapid Long 4-40 triazolam Halcion Intermediate Very short 0.125-0.5 temazepam Restoril Short Short 7.5-30 3 4 1 2019 PCB Conference: Strickland Issues with BZDs Herbal Medication and Alternative Therapies Used in the Treatment of Depression and Anxiety • Addictive potential • Confusion between “anti-anxiety” effects and the “warm-fuzzy) • Large dose ranges • Comparison of BZDs with medications like Buspar, etc. • They work, they work well and they work quickly 5 6 Alternative Tx. Learning Objectives Background Information on herbals: Natural does not necessarily mean “safe” • List several amino acid treatments for depression • Side-effects and adverse reactions • List at least three of the most common herbal – Herbal medications are “drugs” although
    [Show full text]
  • Benzodiazepines: Uses and Risks Charlie Reznikoff, MD Hennepin Healthcare
    Benzodiazepines: Uses and Risks Charlie Reznikoff, MD Hennepin healthcare 4/22/2020 Overview benzodiazepines • Examples of benzos and benzo like drugs • Indications for benzos • Pharmacology of benzos • Side effects and contraindications • Benzo withdrawal • Benzo tapers 12/06/2018 Sedative/Hypnotics • Benzodiazepines • Alcohol • Z-drugs (Benzo-like sleeping aids) • Barbiturates • GHB • Propofol • Some inhalants • Gabapentin? Pregabalin? 12/06/2018 Examples of benzodiazepines • Midazolam (Versed) • Triazolam (Halcion) • Alprazolam (Xanax) • Lorazepam (Ativan) • Temazepam (Restoril) • Oxazepam (Serax) • Clonazepam (Klonopin) • Diazepam (Valium) • Chlordiazepoxide (Librium) 4/22/2020 Sedatives: gaba stimulating drugs have incomplete “cross tolerance” 12/06/2018 Effects from sedative (Benzo) use • Euphoria/bliss • Suppresses seizures • Amnesia • Muscle relaxation • Clumsiness, visio-spatial impairment • Sleep inducing • Respiratory suppression • Anxiolysis/disinhibition 12/06/2018 Tolerance to benzo effects? • Effects quickly diminish with repeated use (weeks) • Euphoria/bliss • Suppresses seizures • Effects incompletely diminish with repeated use • Amnesia • Muscle relaxation • Clumsiness, visio-spatial impairment • Seep inducing • Durable effects with repeated use • Respiratory suppression • Anxiolysis/disinhibition 12/06/2018 If you understand this pharmacology you can figure out the rest... • Potency • 1 mg diazepam <<< 1 mg alprazolam • Duration of action • Half life differences • Onset of action • Euphoria, clinical utility in acute
    [Show full text]
  • Is Alcohol Use Related to High Cholesterol in Premenopausal
    Research iMedPub Journals Journal of Preventive Medicine 2018 http://www.imedpub.com/ Vol.3 No.1:3 ISSN 2572-5483 DOI: 10.21767/2572-5483.100024 Is Alcohol Use Related To High Cholesterol in Premenopausal Women Aged 40-51 Years Old? Sydnee Homeyer, Jessica L Hartos*, Holli Lueg, Jessica Moore and Patricia Stafford Department of Physician Assistant Studies, University of North Texas Health Science Center, USA *Corresponding author: Jessica L. Hartos, Department of Physician Assistant Studies, University of North Texas Health Science Center, USA, Tel: 817-735-2454; Fax: 817-735-2529; E-mail: Jessica.hartos@unthsc.edu Received date: November 13, 2017; Accepted date: January 8, 2018; Publication date: January 15, 2018 Citation: Homeyer S, Hartos JL, Lueg H, Moore J, Stafford P, et al. (2018) Is Alcohol Use Related To High Cholesterol In Premenopausal Women Aged 40-51 Years Old? J Prev Med Vol.3 No.3: 3. Copyright: © 2018 Homeyer S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. Introduction Abstract Increased serum cholesterol levels is a major risk factor for coronary heart disease (CHD) [1], and over seventy-one million Purpose: Alcohol use and cholesterol are related in men and American adults have high cholesterol (27%) [2,3]. In American postmenopausal women but relations between alcohol use women, cholesterol levels have been shown to increase with and cholesterol are unclear for premenopausal women. The age, and nearly 1 in 2 American women has high or borderline purpose of this study was to determine whether alcohol use was related to cholesterol in women aged 40-51 years old.
    [Show full text]
  • E the Effect of Topiramate on Weight Loss in Patients with Type 2 Diabetes
    E The effect of topiramate on weight loss in patients with type 2 diabetes RTICL Sedighe Moradi, Scott Reza Jafarian Kerman, Mina Mollabashi A Institute of Endocrinology and Metabolism (Hemmat Campus), Firoozgar Hospital, Tehran University of Medical Sciences, Tehran, Iran Background: Obesity has been associated with several co‑morbidities such as diabetes and increased mortality. In general, the use of medication promotes only a modest weight loss in the range of 2 to 10 kg, usually most effective during the first 6 months of therapy; however, studies have shown positive effects on other risk factors such as blood pressure and serum glucose levels, but there are fewer studies in patients with diabetes. The aim of this study was to assess the effect of topiramate on weight reduction patients with type 2 diabetes. Materials and Methods: This was a 32‑week randomized clinical trial study of 69 subjects during 2008‑2010. RIGINAL Patients, in two treatment groups were given topiramate (39 patients) and Placebo (30 patients) and were subjected to participation in a non‑pharmacologic lifestyle intervention program; which were randomly allocated in our two groups. The percentage change in body O weight and Body Mass Index (BMI) at the end of the study was the primary efficacy endpoint and secondary indicators were changes in blood pressure (BP), proportion of subjects who achieved 5% or 10% weight loss, changes in lipid profile (total cholesterol, low‑density lipoprotein cholesterol, high‑density lipoprotein cholesterol, triglycerides); and changes in glycosylated hemoglobin (HgA1c). Paired samples and independent samples t‑test was used for statistical analysis.
    [Show full text]
  • Deliberate Self-Poisoning with a Lethal Dose of Pentobarbital: Survival with Supportive Care
    Deliberate self-poisoning with a lethal dose of pentobarbital: Survival with supportive care. (1) (1,2) Santosh Gone , Andis Graudins (1) Clinical Toxicology Service, Program of Emergency Medicine, Monash Health (2) Monash Emergency Research Collaboration, Clinical Sciences at Monash Health, Monash University Abstract 84 INTRODUCTION CASE REPORT (continued) DISCUSSION Pentobarbital (Nembutal) is short acting In the ED: Pentobarbital has been a banned substance for barbiturate sedative-hypnotic, currently widely GCS: 3/15, fixed dilated pupils, apnoeic and human use in Australia since 1998. However, it can used in veterinary practice for anesthesia and ventilated. be procured overseas or bought on the internet. euthanasia. Pulse: 116 bpm sinus tachycardia BP: 115/60 on epinephrine infusion. Pentobarbital is recommended as an effective It is also commonly recommended as a VBG: pH 7.03 pCO2 77 mmHg Bicarb 19 mmol/L agent for use in euthanasia due to its apparently euthanasia drug for assisted suicide and it is Lactate 8.8 mmol/L peaceful transition to death. unlikely that any resuscitative measures will be Activated charcoal (50g) given via an NG tube. attempted in such cases. Course in the Intensive Care Department: In a case series of 150 assisted suicides in Day-1 post-OD: Sweden, a 100% success rate was seen with Intentional overdose results in depression of - Absent brain stem reflexes and fixed dilated pupils for ingestion of 9 grams. Cardiovascular collapse was brain stem function and rapid onset respiratory five days. seen within 15 minutes in 30% of patients. It is rare depression and apnoea. Hypotension also - Diabetes insipidus developed with urine output of to see survival after intentional ingestion for develops, followed by cardiovascular collapse 300ml/hour.
    [Show full text]
  • Pharmacology on Your Palms CLASSIFICATION of the DRUGS
    Pharmacology on your palms CLASSIFICATION OF THE DRUGS DRUGS FROM DRUGS AFFECTING THE ORGANS CHEMOTHERAPEUTIC DIFFERENT DRUGS AFFECTING THE NERVOUS SYSTEM AND TISSUES DRUGS PHARMACOLOGICAL GROUPS Drugs affecting peripheral Antitumor drugs Drugs affecting the cardiovascular Antimicrobial, antiviral, Drugs affecting the nervous system Antiallergic drugs system antiparasitic drugs central nervous system Drugs affecting the sensory Antidotes nerve endings Cardiac glycosides Antibiotics CNS DEPRESSANTS (AFFECTING THE Antihypertensive drugs Sulfonamides Analgesics (opioid, AFFERENT INNERVATION) Antianginal drugs Antituberculous drugs analgesics-antipyretics, Antiarrhythmic drugs Antihelminthic drugs NSAIDs) Local anaesthetics Antihyperlipidemic drugs Antifungal drugs Sedative and hypnotic Coating drugs Spasmolytics Antiviral drugs drugs Adsorbents Drugs affecting the excretory system Antimalarial drugs Tranquilizers Astringents Diuretics Antisyphilitic drugs Neuroleptics Expectorants Drugs affecting the hemopoietic system Antiseptics Anticonvulsants Irritant drugs Drugs affecting blood coagulation Disinfectants Antiparkinsonian drugs Drugs affecting peripheral Drugs affecting erythro- and leukopoiesis General anaesthetics neurotransmitter processes Drugs affecting the digestive system CNS STIMULANTS (AFFECTING THE Anorectic drugs Psychomotor stimulants EFFERENT PART OF THE Bitter stuffs. Drugs for replacement therapy Analeptics NERVOUS SYSTEM) Antiacid drugs Antidepressants Direct-acting-cholinomimetics Antiulcer drugs Nootropics (Cognitive
    [Show full text]
  • Choice of Drugs in the Treatment of Rheumatoid Arthritis
    RHEUMATOLOGY IN GENERAL PRACTICE 7 Those with predominant but never exclusive involvement of the terminal finger joint, usually associated with changes in the nail of the same finger; they are serologically negative. There may be a swollen finger with loss of the skin markings-a sort of dactylitis, again serologically negative. (2) Those with a much more severe process which produces loss of movement in the spine and changes in the sacroiliac joints much the same as those in ankylosing spondylitis; unlike ankylosing spondylitis, it produces severe deformity often with ankylosis in peripheral joints. Many of the finger joints become deformed and ankylosed. (3) Those cases indistinguishable from rheumatoid arthritis although the majority are sero-negative. The Stevens Johnson syndrome produces acute effusions, particularly in large joints. It is sometimes associated with the rash of erythema multiforme, always with ulceration in the mouth and genital tract; the mouth ulcers are accompanied by sloughing, unlike those of Beh9et's syndrome which we come to next. BehCet's syndrome, originally described as a combination of orogenital ulceration with relapsing iritis, is now expanded to include skin lesions, other eye lesions, lesions of the central nervous system, thrombophlebitis migrans, and arthropathy (occurring in 64 per cent). The onset is acute, often affecting only a single joint and settling without residual trouble. Choice of drugs in the treatment of rheumatoid arthritis Dr Dudley Hart, M.D., F.R.C.P. (Consultant physician, Westminster Hospital and Medical School) There are many potential drugs for the treatment of rheumatoid disease, but what are we treating in this disorder? Pain in rheumatoid arthritis is but one of the symp- toms.
    [Show full text]
  • Kava Kava Extract Is Available from Ashland Chemical Co., Mini Star International, Inc., and QBI (Quality Botanical Ingredients, Inc.)
    SUMMARY OF DATA FOR CHEMICAL SELECTION Kava Kava 9000-38-8; 84696-40-2 November 1998 TABLE OF CONTENTS Basis for Nomination Chemical Identification Production Information Use Pattern Human Exposure Regulatory Status Evidence for Possible Carcinogenic Activity Human Data Animal Data Metabolism Other Biological Effects Structure-Activity Relationships References BASIS OF NOMINATION TO THE CSWG Kava kava is brought to the attention of the CSWG because it is a rapidly growing, highly used dietary supplement introduced into the mainstream U.S. market relatively recently. Through this use, millions of consumers using antianxiety preparations are potentially exposed to kava kava. A traditional beverage of various Pacific Basin countries, kava clearly has psychoactive properties. The effects of its long-term consumption have not been documented adequately; preliminary studies suggest possibly serious organ system effects. The potential carcinogenicity of kava and its principal constituents are unknown. INPUT FROM GOVERNMENT AGENCIES/INDUSTRY The U.S. Pharmacopeia is in the process of reviewing kava kava. No decision on preparation of a monograph has been made. SELECTION STATUS ACTION BY CSWG: 12/14/98 Studies requested: - Toxicological evaluation, to include studies of reproductive toxicity and neurotoxicity - Genotoxicity Priority: High Rationale/Remarks: - Significant human exposure - Leading dietary supplement with rapidly growing use - Concern that kava has been promoted as a substitute for ritilin in children - Test extract standardized to 30 percent kavalactones - NCI is conducting studies in Salmonella typhimurium CHEMICAL IDENTIFICATION CAS Registry Number: 9000-38-8 Kava-kava resin (8CI) Chemical Abstract Service Name: 84696-40-2 CAS Registry Number: Pepper (Piper), P. methysticum, ext. Chemical Abstract Service Name: Extract of kava; kava extract; Piper Synonyms and Trade Names: methisticum extract Description: The tropical shrub Piper methysticum is widely cultivated in the South Pacific.
    [Show full text]
  • Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence
    International Journal of Molecular Sciences Review Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence Giulia Maria Camerino 1, Nancy Tarantino 1 , Ileana Canfora 1 , Michela De Bellis 1, Olimpia Musumeci 2 and Sabata Pierno 1,* 1 Section of Pharmacology, Department of Pharmacy and Drug Sciences, University of Bari “Aldo Moro”, 70125 Bari, Italy; giuliamaria.camerino@uniba.it (G.M.C.); nancy.tarantino@uniba.it (N.T.); ileana.canfora@uniba.it (I.C.); michela.debellis@uniba.it (M.D.B.) 2 Unit of Neurology and Neuromuscular Disorders, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; omusumeci@unime.it * Correspondence: sabata.pierno@uniba.it Abstract: Statins are the most prescribed and effective drugs to treat cardiovascular diseases (CVD). Nevertheless, these drugs can be responsible for skeletal muscle toxicity which leads to reduced compliance. The discontinuation of therapy increases the incidence of CVD. Thus, it is essential to assess the risk. In fact, many studies have been performed at preclinical and clinical level to investigate pathophysiological mechanisms and clinical implications of statin myotoxicity. Conse- quently, new toxicological aspects and new biomarkers have arisen. Indeed, these drugs may affect gene transcription and ion transport and contribute to muscle function impairment. Identifying a marker of toxicity is important to prevent or to cure statin induced myopathy while assuring the right therapy for hypercholesterolemia and counteracting CVD. In this review we focused on the mechanisms of muscle damage discovered in preclinical and clinical studies and highlighted the Citation: Camerino, G.M.; Tarantino, pathological situations in which statin therapy should be avoided.
    [Show full text]
  • Tegretol (Carbamazepine)
    Page 3 Tegretol® carbamazepine USP Chewable Tablets of 100 mg - red-speckled, pink Tablets of 200 mg – pink Suspension of 100 mg/5 mL Tegretol®-XR (carbamazepine extended-release tablets) 100 mg, 200 mg, 400 mg Rx only Prescribing Information WARNING SERIOUS DERMATOLOGIC REACTIONS AND HLA-B*1502 ALLELE SERIOUS AND SOMETIMES FATAL DERMATOLOGIC REACTIONS, INCLUDING TOXIC EPIDERMAL NECROLYSIS (TEN) AND STEVENS-JOHNSON SYNDROME (SJS), HAVE BEEN REPORTED DURING TREATMENT WITH TEGRETOL. THESE REACTIONS ARE ESTIMATED TO OCCUR IN 1 TO 6 PER 10,000 NEW USERS IN COUNTRIES WITH MAINLY CAUCASIAN POPULATIONS, BUT THE RISK IN SOME ASIAN COUNTRIES IS ESTIMATED TO BE ABOUT 10 TIMES HIGHER. STUDIES IN PATIENTS OF CHINESE ANCESTRY HAVE FOUND A STRONG ASSOCIATION BETWEEN THE RISK OF DEVELOPING SJS/TEN AND THE PRESENCE OF HLA-B*1502, AN INHERITED ALLELIC VARIANT OF THE HLA-B GENE. HLA-B*1502 IS FOUND ALMOST EXCLUSIVELY IN PATIENTS WITH ANCESTRY ACROSS BROAD AREAS OF ASIA. PATIENTS WITH ANCESTRY IN GENETICALLY AT- RISK POPULATIONS SHOULD BE SCREENED FOR THE PRESENCE OF HLA-B*1502 PRIOR TO INITIATING TREATMENT WITH TEGRETOL. PATIENTS TESTING POSITIVE FOR THE ALLELE SHOULD NOT BE TREATED WITH TEGRETOL UNLESS THE BENEFIT CLEARLY OUTWEIGHS THE RISK (SEE WARNINGS AND PRECAUTIONS/LABORATORY TESTS). APLASTIC ANEMIA AND AGRANULOCYTOSIS APLASTIC ANEMIA AND AGRANULOCYTOSIS HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE OF TEGRETOL. DATA FROM A POPULATION-BASED CASE CONTROL STUDY DEMONSTRATE THAT THE RISK OF DEVELOPING THESE REACTIONS IS 5-8 TIMES GREATER THAN IN THE GENERAL POPULATION. HOWEVER, THE OVERALL RISK OF THESE REACTIONS IN THE UNTREATED GENERAL POPULATION IS LOW, APPROXIMATELY SIX PATIENTS PER ONE MILLION POPULATION PER YEAR FOR AGRANULOCYTOSIS AND TWO PATIENTS PER ONE MILLION POPULATION PER YEAR FOR APLASTIC ANEMIA.
    [Show full text]
  • Alcohol and the Cardiovascular System
    Alcohol and the Cardiovascular System Molecular Mechanisms for Beneficial and Harmful Action SAM ZAKHARI, PH.D. Alcohol can be beneficial or harmful to the cardiovascular system, depending on the amount consumed and the characteristics of the consumer. Of the numerous cellular and molecular mechanisms that are thought to explain the beneficial effects of moderate drinking, this article discusses four, involving (1) high density lipoproteins, (2) cellular signaling, (3) platelet function in blood clot formation, and (4) stimulation of blood clot dissolution. Although light-to-moderate drinking can protect against coronary artery disease, heavy alcohol consumption can damage the cardiovascular system, resulting in maladies such as heart muscle disorders, irregular heart rhythms, high blood pressure, and strokes. This article summarizes representative epidemiological and animal studies on these cardiovascular consequences of chronic heavy alcohol consumption and reviews mechanisms that have been suggested to explain alcohol’s effects. KEY WORDS: chronic AODE (alcohol and other drug effects); molecular interaction; biochemical mechanism; lipoproteins; platelets; blood coagulation; moderate AOD use; heavy AOD use; therapeutic drug effect; AODR (alcohol and other drug related) disorder; alcoholic cardiomyopathy; cardiac arrhythmia; hypertensive disorder; stroke; literature review; cell signaling lcoholic beverages have been sumed. This chronic heavy drinking1 is used—and abused—since the 1The term “heavy drinking” is not used consistently in a significant factor in the development the alcohol literature; therefore, this article generally dawn of history. Although most 2 A of alcohol dependence, or alcoholism, refers to “heavy drinking” and “heavy drinkers” based people who choose to drink can limit their and is associated with serious adverse on the terms used in the reference cited.
    [Show full text]